Bob Radie Presents Neuraptive Therapeutics at LSI USA '23

Neuraptive Therapeutics' product is designed for administration during surgery to improve outcomes for patients impacted by acute nerve injury repairs and reconstructive surgical procedures involving peripheral nerves.
Join Our Next Event
Partner with the leaders
shaping the future of
Medtech at LSI USA ‘26
March 16th - 20th, 2026
Waldorf Astoria, Monarch Beach
Speakers
Bod Radie
Bod Radie
Chairman & CEO, Neuraptive Therapeutics